Osprey Medical INC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$205Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
387clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Nandish Thukral | San Antonio, TX | Interventional Cardiology | $38,977.99 |
| Anand Prasad | San Antonio, TX | Interventional Cardiology | $32,411.77 |
| Hitinder Gurm | Ann Arbor, MI | Cardiovascular Disease | $26,888.00 |
| Shweta Bansal | San Antonio, TX | Nephrology (Internal Medicine) | $16,563.00 |
| Vishal Gupta | Kalamazoo, MI | Interventional Cardiology | $12,155.00 |
| Prakash Balan | Chandler, AZ | Interventional Cardiology | $7,325.27 |
| Gautam Kumar | Atlanta, GA | Cardiovascular Disease | $6,893.00 |
| Miguel Diaz | Hialeah, FL | Interventional Cardiology | $5,582.24 |
| Paul Tucker | Austin, TX | Interventional Cardiology | $4,078.95 |
| Barry Bertolet | Tupelo, MS | Cardiovascular Disease | $3,744.38 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.